An Open-Label Extension Study to Assess the Long-Term Efficacy and Safety of a Plasma-Derived von Willebrand Factor (VWF)/Factor VIII (FVIII) Concentrate in Patients with von Willebrand Disease (SWIFT-VWDext Study)
Lissitchkov, Toshko, Klukowska, Anna, Buevich, Evgeny, Maltceva, Irina, Auerswald, Guenter, Stasyshyn, Oleksandra, Seifert, Wilfried, Rogosch, TobiasVolume:
Volume 11
Journal:
Journal of Blood Medicine
DOI:
10.2147/JBM.S268907
Date:
October, 2020
File:
PDF, 1.53 MB
2020